Solid Tumor Clinical Trials

A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 2021 clinical trials
A Phase I Study of AL8326 in Advanced Solid Tumor

Main purpose Objective to study the tolerance and safety of single and multiple administration of repeated 28-day cycles of AL8326 in patients with advanced solid tumor, observe the dose

  • 24 May, 2021
  • 2 locations
MRI in Diagnosing Solid Tumors of the Eye and Orbit

This study is being done due to a new imaging method that may help others in the future to improve evaluation of diseases in the eye and eye socket and to help make a decision concerning best treatment of the disease. Previous studies suggests that dynamic contrast enhanced MRI is …

  • 28 Apr, 2022
  • 1 location
Treatment of Advanced and Metastatic Solid Tumors With MIL97

advanced or metastatic solid tumor. The study consists of a dose escalation phase and a dose expansion phase. An accelerated titration design (cohorts 1-2 only) followed by 3+3 dose-escalation design will

  • 18 Jun, 2022
  • 1 location
Study on TIL for the Treatment of Advanced Solid Tumors

This study is to investigate the safety and efficacy of tumor infiltrating lymphocyte (TIL) therapy in patients with Advanced malignant solid tumors.Autologous TILs are expanded from tumor resections or biopsies and infused i.v. into the patient after NMA lymphodepletion treatment with fludarabine and cyclophosphamide.

  • 07 Jul, 2022
  • 1 location
Study of RP-6306 With Gemcitabine in Advanced Solid Tumors

The primary purpose of this study is to assess the safety and tolerability of RP-6306 in combination gemcitabine, in patients with eligible advanced solid tumors, determine the maximum tolerated

  • 28 May, 2022
  • 3 locations
A Study of SKB315 in Patients With Advanced Solid Tumors

injection in patients with advanced solid tumors.

  • 26 May, 2022
  • 1 location
A Study of ASP1570 in Adults With Advanced Solid Tumors

This study is for adults with advanced solid tumors. Their tumor has either grown outside of the area where it started or it has spread to other parts of the body. Their cancer gets worse after

  • 22 Jul, 2022
  • 8 locations
First in Human Study of M1069 in Advanced Solid Tumors

The main purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and early signs of efficacy of M1069 in participants with advanced solid malignancies.

  • 25 Jul, 2022
  • 3 locations
Phase I of Eribulin and Oral Irinotecan for Relapsed or Refractory Solid Tumors

This Phase I trial will establish the recommended phase II dose of eribulin in combination with fixed doses of oral irinotecan in adolescents and young adults with relapsed or refractory solid

  • 08 Nov, 2020
  • 1 location
TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors

TLD-1 is a novel liposomal formulation of doxorubicin (PEG surface) that compared favorably to conventional liposomal formulations of doxorubicin including Caelyx® in preclinical in vivo models. Particle features including size, charge distribution, lipid composition and drug release add up to a considerably altered particle behavior compared to Caelyx®, potentially explaining …

  • 14 Feb, 2022
  • 3 locations